By the same authors

From the same journal

From the same journal

Building castles on sands or quicksands? The strengths and weaknesses of economic evaluation in pharmaceuticals

Research output: Contribution to journalArticle

Standard

Building castles on sands or quicksands? The strengths and weaknesses of economic evaluation in pharmaceuticals. / Maynard, A; Bloor, K.

In: British Journal of Psychiatry, Vol. 173, 09.1998, p. 12-18.

Research output: Contribution to journalArticle

Harvard

Maynard, A & Bloor, K 1998, 'Building castles on sands or quicksands? The strengths and weaknesses of economic evaluation in pharmaceuticals', British Journal of Psychiatry, vol. 173, pp. 12-18.

APA

Maynard, A., & Bloor, K. (1998). Building castles on sands or quicksands? The strengths and weaknesses of economic evaluation in pharmaceuticals. British Journal of Psychiatry, 173, 12-18.

Vancouver

Maynard A, Bloor K. Building castles on sands or quicksands? The strengths and weaknesses of economic evaluation in pharmaceuticals. British Journal of Psychiatry. 1998 Sep;173:12-18.

Author

Maynard, A ; Bloor, K. / Building castles on sands or quicksands? The strengths and weaknesses of economic evaluation in pharmaceuticals. In: British Journal of Psychiatry. 1998 ; Vol. 173. pp. 12-18.

Bibtex - Download

@article{7355df90974948b4bbde84eb0adf2f35,
title = "Building castles on sands or quicksands? The strengths and weaknesses of economic evaluation in pharmaceuticals",
keywords = "NONSTEROIDAL ANTIINFLAMMATORY DRUGS, SCHIZOPHRENIC-PATIENTS, DOUBLE-BLIND, RESISTANT SCHIZOPHRENIA, COST-EFFECTIVENESS, RISPERIDONE, CLOZAPINE, TRIALS, ARTHRITIS, BENEFITS",
author = "A Maynard and K Bloor",
year = "1998",
month = "9",
language = "English",
volume = "173",
pages = "12--18",
journal = "British Journal of Psychiatry",
issn = "0007-1250",
publisher = "Royal College of Psychiatrists",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Building castles on sands or quicksands? The strengths and weaknesses of economic evaluation in pharmaceuticals

AU - Maynard, A

AU - Bloor, K

PY - 1998/9

Y1 - 1998/9

KW - NONSTEROIDAL ANTIINFLAMMATORY DRUGS

KW - SCHIZOPHRENIC-PATIENTS

KW - DOUBLE-BLIND

KW - RESISTANT SCHIZOPHRENIA

KW - COST-EFFECTIVENESS

KW - RISPERIDONE

KW - CLOZAPINE

KW - TRIALS

KW - ARTHRITIS

KW - BENEFITS

M3 - Article

VL - 173

SP - 12

EP - 18

JO - British Journal of Psychiatry

T2 - British Journal of Psychiatry

JF - British Journal of Psychiatry

SN - 0007-1250

ER -